Related Experiment Video
Updated: Jun 18, 2025

Author Spotlight: Advancing Techniques and Discoveries in Protein Synthesis and Assembly Through Innovative Mitochondrial Research
Published on: June 7, 2024
MGA deletion leads to Richter's transformation by modulating mitochondrial OXPHOS
Prajish Iyer1, Bo Zhang1, Tingting Liu2
1Department of Systems Biology, Beckman Research Institute, City of Hope National Comprehensive Cancer Center, Monrovia, CA 91016, USA.
Abstract:
Richter's transformation (RT) is a progression of chronic lymphocytic leukemia (CLL) to aggressive lymphoma. MGA (Max gene associated), a functional MYC suppressor, is mutated at 3% in CLL and 36% in RT. However, genetic models and molecular mechanisms of MGA deletion that drive CLL to RT remain elusive. We established an RT mouse model by knockout of Mga in the Sf3b1/Mdr CLL model using CRISPR-Cas9 to determine the role of Mga in RT. Murine RT cells exhibited mitochondrial aberrations with elevated oxidative phosphorylation (OXPHOS). Through RNA sequencing and functional characterization, we identified Nme1 (nucleoside diphosphate kinase) as an Mga target, which drives RT by modulating OXPHOS. Given that NME1 is also a known MYC target without targetable compounds, we found that concurrent inhibition of MYC and electron transport chain complex II substantially prolongs the survival of RT mice in vivo. Our results suggest that the Mga-Nme1 axis drives murine CLL-to-RT transition via modulating OXPHOS, highlighting a potential therapeutic avenue for RT.
Insights
Richter's transformation (RT) involves chronic lymphocytic leukemia (CLL) progressing to lymphoma. MGA gene deletion drives RT by altering oxidative phosphorylation via NME1, suggesting new therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Richter's transformation (RT) is the progression of chronic lymphocytic leukemia (CLL) to aggressive lymphoma.
- Max gene associated (MGA), a MYC suppressor, is frequently mutated in RT, but its role in disease progression is unclear.
- Genetic models for MGA deletion in CLL-to-RT transition are lacking.
Purpose of the Study:
- To establish a mouse model for RT via MGA knockout.
- To elucidate the molecular mechanisms by which MGA deletion drives CLL to RT.
- To identify potential therapeutic strategies for RT.
Main Methods:
- CRISPR-Cas9 gene editing to create an RT mouse model by knocking out Mga in an existing CLL model.
- RNA sequencing and functional characterization of RT cells.
- In vivo studies evaluating therapeutic interventions.
Main Results:
- The Mga-deficient CLL model recapitulated RT features, including mitochondrial aberrations and elevated oxidative phosphorylation (OXPHOS).
- Nme1 (nucleoside diphosphate kinase) was identified as a direct Mga target driving RT through OXPHOS modulation.
- Concurrent inhibition of MYC and electron transport chain complex II significantly improved survival in RT mice.
Conclusions:
- The Mga-Nme1 axis is a key driver of CLL to RT progression by modulating OXPHOS.
- Targeting MYC and electron transport chain complex II represents a promising therapeutic strategy for RT.
- This study provides a novel genetic model and mechanistic insights into RT pathogenesis.
More Related Videos
Related Concept Videos
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
ATP Synthase: Mechanism
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondria
Mitochondrial Membranes
Pyruvate Oxidation
First, the enzyme pyruvate dehydrogenase removes the carboxyl group from pyruvate and releases it as carbon dioxide. The stripped molecule is then oxidized and releases electrons, which are then picked up by NAD+...

